#AIEye
#Podcast 584: #Stocks discussed: (NasdaqGS: $TWST) (NYSE: $MDLA)
#artificialintelligence
Twist
Bioscience Uses AI from MOLCURE for Antibody Discovery, and Medallia to be
Acquired by Thoma Bravo
Global
#AI in Diagnostics Market to Reach $5.37B by 2028
Point Roberts WA, Vancouver BC – July 26, 2021 – Investorideas.com (www.investorideas.com), a global investor news source covering
Artificial Intelligence (AI) brings you today’s edition of The
AI Eye- watching stock news, deal tracker and advancements in
artificial intelligence
Listen
to today’s podcast:
https://www.investorideas.com/Audio/Podcasts/2021/072621-AI-Eye.mp3
Read
this in full at https://www.investorideas.com/news/2021/artificial-intelligence/07261TWST-MDLA.asp
Today’s
Column- The
AI Eye- Watching stock news, deal tracker and advancements
in artificial intelligence
Stocks
discussed: (NasdaqGS:TWST) (NYSE:MDLA)
Synthetic biology and genomics company Twist Bioscience
Corporation (NasdaqGS:TWST) is incorporating AI technology from MOLCURE Inc.
to augment therapeutic antibody discovery. Emily Leproust, CEO and co-founder
of Twist Bioscience, commented:
"Twist
Bioscience continues to innovate and incorporate the most advanced methods of
antibody discovery and optimization into our processes. MOLCURE’s AI approach
complements our proprietary antibody discovery and optimization efforts,
leveraging technology to refine our internal antibody pipeline. Their platform
enables us to find more leads derived from NGS sequencing from our library. We
look forward to taking leads generated from this collaboration forward within
our internal pipeline."
Medallia, Inc. (NYSE:MDLA) has entered into a definitive
agreement to be acquired by software investment firm Thoma
Bravo in an all-cash transaction valuing the former at $6.4 billion. According
to the press release, this will see Medallia “become a private company with
additional resources and greater flexibility to build on its innovation
leadership and expand its customer impact.” Scott Crabill, a Managing Partner
at Thoma Bravo, said:
"Medallia
has positioned itself at the forefront of the experience management market with
a best-in-class SaaS platform that leverages proprietary AI to help companies
better understand their customers and employees and drive meaningful business
growth at scale. Medallia’s ability to provide personalized and predictive
insights across every channel and to companies of all sizes has become
mission-critical in a rapidly expanding universe of structured and unstructured
data, where more and more business is transacted digitally. We look forward to
partnering with Leslie and the talented Medallia team and applying our
operational and investment expertise in software to support the company in the
next phase of its growth journey."
Global
AI in Diagnostics Market to Reach $5.37B by 2028
A report published by Verified Market Research finds that the global AI in Diagnostics market will grow from
$532.22 million in 2020 to $5.37 billion by 2028, registering a compound annual
growth rate (CAGR) of 33.23 percent in the forecast period 2021-2028. An
excerpt from the report’s description reads:
Key
factors that are driving the market growth include the growing demand for
reducing diagnostic cost, improving patient care, reducing machine downtime
coupled with growing demand for low-cost diagnostic techniques, effective &
efficient report analysis, and quick diagnostic data generation. Furthermore,
advancements in AI and deep learning are expected to prove more efficient in
identifying disease diagnoses over the next few years. Increasing adoption of
AI-based diagnostics across the developed economies fosters market growth. For
the past couple of decades, technological advancements in the healthcare sector
are playing a vital role in strengthening the global healthcare infrastructure.
Sam Mowers, Investorideas.com
Read and
hear other editions of the AI Eye
For a list of artificial intelligence
stocks on Investorideas.com visit
here
Investors can trade these stocks and
other ideas on our site using our list of top stock trading apps including Robinhood , Acorn, Stash and others.
About
Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com
publishes breaking stock news, third party stock research, guest posts and
original articles and podcasts in leading stock sectors. Learn about investing in stocks and get
investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy, gaming and more. Investor Idea’s original branded content
includes podcasts and columns : Crypto Corner , Play
by Play sports and stock
news , Investor Ideas Potcasts
Cannabis News and Stocks on the Move podcast ,
Cleantech
and Climate Change , Exploring
Mining , Betting
on Gaming Stocks Podcast and the AI
Eye
Podcast.
The Investorideas.com podcasts are also
available on iTunes ( Apple Podcasts) ,
Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio, Google
Play Music and most audio platforms available.
Visit the Podcast page at
Investorideas.com:
https://www.investorideas.com/Audio/
Disclaimer/Disclosure: Investorideas.com is a digital publisher of
third party sourced news, articles and equity research as well as creates
original content, including video, interviews and articles. Original content
created by investorideas is protected by copyright laws other than syndication
rights. Our site does not make recommendations for purchases or sale of stocks,
services or products. Nothing on our sites should be construed as an offer or
solicitation to buy or sell products or securities. All investing involves risk
and possible losses. This site is currently compensated for news publication
and distribution, social media and marketing, content creation and more.
Disclosure is posted for each compensated news release, content published
/created if required but otherwise the news was not compensated for and was
published for the sole interest of our readers and followers. Contact
management and IR of each company directly regarding specific questions. More
disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about
publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com Global investors
must adhere to regulations of each country. Please read Investorideas.com
privacy policy: https://www.investorideas.com/About/Private_Policy.asp
The AI Eye- Watching stock news, deal tracker and
advancements in artificial intelligence is an original content brand of
Investorideas.com
Follow us on
Twitter https://twitter.com/Investorideas
Follow us on
Facebook https://www.facebook.com/Investorideas
Follow us on
YouTube https://www.youtube.com/c/Investorideas
Download our Mobile
App for iPhone and
Android
Join our Investor
Club https://www.investorideas.com/membership/
Contact Investorideas.com
800 665 0411
Get
more Technology stock investor
ideas -
news, articles, podcasts and stock directories
No comments:
Post a Comment